Which Weight Management Injection Suits You Best?
Moving From Mounjaro to Wegovy: Understanding Key Differences
When moving from Mounjaro to Wegovy, the fundamental difference lies in their mechanisms of action and how they may affect your weight management journey. Wegovy contains semaglutide, a selective GLP-1 receptor agonist that mimics your body's natural incretin hormone to regulate appetite and gastric emptying. Mounjaro, conversely, contains tirzepatide, which activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptors simultaneously as a dual agonist.
This mechanistic distinction means patients moving from Mounjaro to Wegovy may experience different appetite suppression patterns and side effect profiles. Wegovy's singular GLP-1 focus has been extensively studied in the landmark STEP trials, demonstrating consistent efficacy across diverse patient populations. The transition between these treatments requires careful medical supervision, as dose escalation protocols differ significantly between the two prescription-only medicines.
Wegovy vs Mounjaro Pricing: Complete Cost Comparison
EverydayMeds offers transparent pricing for both treatments, with Wegovy single pens starting from £79.99 for the 0.25mg starter dose (weeks 1-4). The complete Wegovy dose escalation includes 0.5mg at £94.99 (weeks 5-8), 1mg at £99.99 (weeks 9-12), 1.7mg at £139.99 (weeks 13-16), and 2.4mg maintenance at £209.99 (weeks 17+). New customers benefit from code FIRST40, whilst returning customers use code DOSE25 at checkout to access these competitive prices.
For those moving from Mounjaro to Wegovy, our Getting Started bundles provide excellent value and convenience. The Intro Trio (0.25mg, 0.5mg, and 1mg) costs £299.99, covering your first 12 weeks of treatment with Reliable Supply continuity. The Ultimate Stability Trio offers three months of 2.4mg maintenance therapy for £649.99, ensuring consistent access to your prescribed dose without multiple ordering requirements.
Clinical Evidence for Moving From Mounjaro to Wegovy
Wegovy's clinical foundation rests on the comprehensive STEP trial programme, with STEP 1 demonstrating approximately 15% average weight loss at 68 weeks versus 2.4% with placebo when used alongside diet and exercise modifications (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial further established a 20% reduction in major cardiovascular events, highlighting Wegovy's broader health benefits beyond weight management.
Patients considering moving from Mounjaro to Wegovy should understand that both treatments have demonstrated significant efficacy in clinical trials, though direct head-to-head comparisons remain limited due to different trial designs and populations. The choice between treatments often depends on individual tolerance, injection frequency preferences, and specific medical considerations that your prescribing clinician will evaluate during assessment.
How Wegovy Works When Moving From Mounjaro Treatment
Wegovy functions as a selective GLP-1 receptor agonist, binding specifically to GLP-1 receptors in the brain's appetite control centres, pancreas, and gastrointestinal tract. This targeted action slows gastric emptying, meaning food remains in your stomach longer, promoting sustained feelings of fullness after smaller meals. The medication also influences hypothalamic appetite regulation, potentially reducing food cravings and the psychological drive to eat. Unlike Mounjaro's dual-receptor approach, Wegovy's singular GLP-1 focus provides a well-characterized mechanism that has been studied extensively across multiple patient populations. The once-weekly injection schedule using the convenient FlexTouch pen device ensures consistent therapeutic levels throughout the week, supporting steady appetite regulation and metabolic benefits.
Ordering Process for Moving From Mounjaro to Wegovy
EverydayMeds streamlines your transition with a comprehensive three-minute online clinical assessment that evaluates your current treatment history, including previous Mounjaro experience, to ensure Wegovy suitability. Our qualified prescribers review your application within three working days (or 24 hours with express service), considering your individual medical profile and weight management goals. Once approved, your Wegovy prescription is fulfilled through our GPhC-registered pharmacy (#9012878) with next-day delivery via temperature-controlled cold-chain logistics. Each order includes detailed injection guidance, dose escalation schedules, and access to ongoing clinical support throughout your treatment journey. The process ensures seamless continuity when moving from Mounjaro to Wegovy, with expert oversight at every stage.
Storage and Practical Considerations for Wegovy vs Mounjaro
Wegovy offers superior storage flexibility compared to Mounjaro, remaining stable at room temperature (below 30°C) for up to six weeks once removed from refrigeration, versus Mounjaro's 21-day limit. This advantage proves particularly valuable for frequent travelers or those with limited refrigeration access. The FlexTouch pen delivery system provides consistent, accurate dosing with a simple twist-and-inject mechanism that many patients find more intuitive than alternative devices. Wegovy's mandatory dose escalation protocol begins at 0.25mg weekly, gradually increasing every four weeks to reach the 2.4mg maintenance dose by week 17, allowing your body to adapt progressively to the medication's effects. Each pen contains four weekly doses, requiring monthly prescription fulfillment to maintain treatment continuity throughout your weight management programme.
Switching Protocols When Moving From Mounjaro to Wegovy
The transition from Mounjaro to Wegovy requires careful consideration of washout periods and dose timing to minimize potential side effects or treatment gaps. Most prescribers recommend allowing at least one week between stopping Mounjaro and initiating Wegovy, though individual circumstances may warrant different approaches based on your tolerance and response history. Starting with Wegovy's lowest 0.25mg dose is essential regardless of your previous Mounjaro dose level, as the medications have different potency profiles and tolerability patterns.
Patients moving from Mounjaro to Wegovy should maintain consistent dietary and exercise habits during the transition period to support optimal treatment outcomes. Our clinical team provides detailed switching guidance, including timeline recommendations, side effect monitoring, and dose escalation adjustments based on your individual response. This personalized approach ensures your move from Mounjaro to Wegovy proceeds smoothly with minimal disruption to your weight management progress.
Expert Support for Your Wegovy vs Mounjaro Decision
EverydayMeds provides unbiased clinical guidance to help determine whether moving from Mounjaro to Wegovy aligns with your treatment goals and medical profile. Our qualified prescribers consider factors including your response to previous GLP-1 treatments, side effect tolerance, lifestyle requirements, and specific health conditions that may influence treatment selection. Both Wegovy and Mounjaro are available through our comprehensive service, ensuring you receive the most appropriate prescription-only medicine for your circumstances. The clinical assessment process evaluates your complete medical history, current medications, and weight management objectives to support informed treatment decisions. With access to both leading weight management injections, we can provide continuity of care whether you choose to continue with Mounjaro or transition to Wegovy, supported by ongoing monitoring and dose optimization throughout your treatment journey.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
